Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Capitainer Secures Three US Patents for Innovative Plasma/Serum Separation Device

Capitainer, a leading Swedish medtech innovator specializing in advanced self-sampling solutions, is proud to announce the grant of three US patents for their soon to be launched plasma/serum separation device. These patents cover the company's technology for automatic separation and metering from whole blood. The company has an expected patent protection until 2042.The United States Patent and Trademark Office (USPTO) has granted Capitainer three patents related to their plasma/serum separation device, Capitainer[®]SEP10. The patents cover the developed microfluidic solutions that enable

Inside information: Turkka Kuusisto appointed CEO of Finnair

Finnair Plc                Stock Exchange Release               11 January 2024 at 8:30 a.m. EET Finnair has appointed Turkka Kuusisto (44, MSc. Tech) as CEO of Finnair and he will start in this role on 11 July 2024 at the latest. Kuusisto joins Finnair from Posti Group Corporation, where he has served as the CEO since 2020. Prior to his CEO role in Posti Group Corporation, Kuusisto served in senior leadership positions in Posti Group Corporation and in Lindorff Group. ”I am happy to welcome Turkka Kuusisto to take the helm of Finnair and drive the next phases of Finnair’s strategy.

Finnish startup Cactos raises over €26M to increase its battery energy storage system portfolio

The increasing popularity of electric vehicles, combined with the volatile energy markets, is boosting the demand for smart energy storage systems.HELSINKI, Finland (January 11th, 2023) Cactos , a developer of smart energy storage systems, has raised over €26M worth of equity investments in its Cactos Fleet Finland Limited Partnership (Company) to finance the growth of its battery energy storage system portfolio. Lead investors in the round are  OP Finland Infrastructure LP and the Finnish Climate Fund. Cactos Fleet Finland LP aims to raise a total of €70M in capital,

The European Medicines Agency’s Scientific Advisory Group (SAG) to discuss the Marketing Authorisation Application for lecanemab

Stockholm, Sweden, January 11, 2024 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the Scientific Advisory Group (SAG) will convene to discuss the Marketing Authorisation Application (MAA) of lecanemab (generic name, brand name: Leqembi®), which is currently under review by the European Medicines Agency (EMA). The meeting of the SAG is expected to take place during the first quarter of 2024.The SAG is convened at the request of the Committee for Medicinal Products for Human Use (CHMP) of the EMA to provide independent advice on scientific or technical

Statement by the independent bid committee of Pagero in relation to the public offer from Thomson Reuters of SEK 40 per share

The independent bid committee of the Board of Directors of Pagero unanimously recommends the shareholders of Pagero to accept the public offer made by Thomson Reuters. Simultaneously, the Bid Committee unanimously withdraws its recommendation of 13 December 2023 to accept the public offer made by Vertex.Background This statement is made by the independent bid committee (the "Bid Committee") of the Board of Directors of Pagero Group AB (publ) ("Pagero" or the "Company") pursuant to section II.19 of the Takeover rules for certain trading platforms (the "Takeover Rules").Thomson Reuters

Capsol Technologies ASA: Capsol Technologies awarded feasibility study from cement producer SCHWENK

Oslo, Norway - 11 January 2024Capsol Technologies has been awarded a feasibility study for the CapsolEoP®(end-of-pipe) carbon capture technology at SCHWENK’s Building Material Group’sBrocēni cement plant in Latvia. The study is for a plant aiming to capture 750000 tonnes of CO2 per annum.SCHWENK Latvija is part of the CCS Baltic Consortium which was included in theprovisional 6th list of Projects of Common Interest by the European Commissionin November 2023, aiming to transport captured CO2 from Lithuania and Latvia topermanent storage sites, potentially in the North Sea.“

Thomson Reuters Corporation, through its wholly-owned subsidiary Thomson Reuters Finance, announces a recommended public cash offer of SEK 40 per share to the shareholders of Pagero

The Offer is not being made, and this press release may not be distributed, directly or indirectly in or into, nor will any tender of shares be accepted from or on behalf of holders in Australia, Belarus, Canada, Hong Kong, India, Japan, New Zealand, Russia, Singapore, South Africa, Switzerland or any other jurisdiction in which the making of the Offer, the distribution of this press release or the acceptance of any tender of shares would contravene applicable laws or regulations or require further offer documents, filings or other measures in addition to those required under Swedish law (

Perinatal depression linked to increased risk of death

Women who suffer depression during or after pregnancy have a higher risk of death by both natural and unnatural causes, a new study of childbirth in Sweden published in The BMJ reports. The increased risk peaks in the month after diagnosis but remains elevated for as long as 18 years afterwards.Women who develop perinatal depression, which is to say depression during pregnancy or shortly after childbirth, are generally twice as likely to die of natural or, as in most cases, unnatural causes. They are six times more likely to commit suicide than women without this form of depression. The

Hunter Group ASA – Key information regarding the Subsequent Offering

Date on which the terms and conditions of the subsequent offering were announced: 10 January 2024 Last day including right: 10 January 2024 Ex-date: 11 January 2024 Record date: 12 January 2024 Date of approval: expected approval by the general meeting on or about 2 February 2024 Maximum number of new shares: 14,200,000 shares Subscription price: NOK 1.75 per share Other information: Completion of Subsequent Offering subject to conditions. The company reserves the right in its sole discretion, as announced on 10 January 2024, to not conduct or to cancel the Subsequent

Hunter Group ASA – Completed Private Placement

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Oslo, 10 January 2024 Hunter Group ASA (the “Company”) refers to the stock exchange release of 10 January 2024 regarding a contemplated private placement of up to the NOK equivalent to USD 12 million. The Company hereby announces that it has

Lucara Announces Recovery Of 166 Carat Type IIa Diamond From The Karowe Mine in Botswana

VANCOUVER, January 10, 2024 /CNW/ (LUC – TSX, LUC – BSE, LUC – Nasdaq Stockholm) Lucara Diamond Corp. (“Lucara” or the “Company”) is pleased to announce the recovery of a 166 carat diamond from its 100% owned Karowe Diamond Mine located in Botswana (images attached). The diamond is described as a Type IIa gem, recovered in the Coarse XRT unit at Karowe from direct milling of ore sourced from the M/PK(S) unit of the South Lobe. William Lamb, CEO commented: “Lucara is pleased to announce the ongoing recovery of large, high-quality diamonds from the Karowe Mine. This diamond is the 328th

DanCann Pharma A/S Completes Issuance (8) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2

COPENHAGEN, Denmark, 10 January 2024 – DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, has today, on 10 January 2024, issued a total of 24,999,999 new shares of nominally DKK 0.0375 each by conversion of debt in the total amount of DKK 500,000 under the instrument issued as of 13 July 2023.As set out in press release published on 17 July 2023, the Company has issued a total of 378 convertible debt instruments, each of an amount of DKK 50,000, equal to an aggregate amount of DKK 18,900,000, and 8,190,000 warrants to Nordic Growth

Nanoform Finland Plc – Manager’s transactions – Albert Hæggström

Company release Nanoform Finland Plc January 10, 2024 23.00 Finnish time / 22.00 Swedish time Nanoform Finland Plc – Manager’s transactions – Albert Hæggström Helsinki, Finland – Manager’s transaction related to Nanoform Finland Plc’s CFO and Board Member Albert Hæggström’s acceptance of stock options: Person subject to the notification requirement Name: Albert Haeggström Position: Chief Financial Officer  Issuer: Nanoform Finland Oyj LEI: 743700JJO2NU8LBS1592 Notification type: INITIAL NOTIFICATION Reference number: 48925/8/8 Transaction date: 2024-01-

Nanoform Finland Plc – Manager’s transactions – David Rowe

Company release Nanoform Finland Plc January 10, 2024 23.00 Finnish time / 22.00 Swedish time Nanoform Finland Plc – Manager’s transactions – David Rowe Helsinki, Finland – Manager’s transaction related to Nanoform Finland Plc’s Head of Manufacturing David Rowe’s acceptance of stock options: Person subject to the notification requirement Name: David Rowe Position: Other senior manager  Issuer: Nanoform Finland Oyj LEI: 743700JJO2NU8LBS1592 Notification type: INITIAL NOTIFICATION Reference number: 48937/6/6 Transaction date: 2024-01-10 Outside a

Nanoform Finland Plc – Manager’s transactions – Edward Hæggström

Company release Nanoform Finland Plc January 10, 2024 23.00 Finnish time / 22.00 Swedish time Nanoform Finland Plc – Manager’s transactions – Edward Hæggström Helsinki, Finland – Manager’s transaction related to Nanoform Finland Plc’s CEO Edward Hæggström’s acceptance of stock options: Person subject to the notification requirement Name: Edward Haeggström Position: Chief Executive Officer Issuer: Nanoform Finland Oyj LEI: 743700JJO2NU8LBS1592 Notification type: INITIAL NOTIFICATION Reference number: 48940/6/6 Transaction date: 2024-01-10 Outside a

Nanoform Finland Plc – Manager’s transactions – Peter Hänninen

Company release Nanoform Finland Plc January 10, 2024 23.00 Finnish time / 22.00 Swedish time Nanoform Finland Plc – Manager’s transactions – Peter Hänninen Helsinki, Finland – Manager’s transaction related to Nanoform Finland Plc’s General Counsel Peter Hänninen’s acceptance of stock options: Person subject to the notification requirement Name: Peter Hänninen Position: Other senior manager  Issuer: Nanoform Finland Oyj LEI: 743700JJO2NU8LBS1592 Notification type: INITIAL NOTIFICATION Reference number: 48914/16/12 Transaction date: 2024-01-10

Nanoform Finland Plc – Manager’s transactions – Christian Jones

Company release Nanoform Finland Plc January 10, 2024 23.00 Finnish time / 22.00 Swedish time Nanoform Finland Plc – Manager’s transactions – Christian Jones Helsinki, Finland – Manager’s transaction related to Nanoform Finland Plc’s CCO Christian Jones’ acceptance of stock options: Person subject to the notification requirement Name: Christian Jones Position: Other senior manager  Issuer: Nanoform Finland Oyj LEI: 743700JJO2NU8LBS1592 Notification type: INITIAL NOTIFICATION Reference number: 48934/8/8 Transaction date: 2024-01-10 Outside a trading

Nanoform Finland Plc – Manager’s transactions – Antonio Da Silva

Company release Nanoform Finland Plc January 10, 2024 23.00 Finnish time / 22.00 Swedish time Nanoform Finland Plc – Manager’s transactions – Antonio Da Silva Helsinki, Finland – Manager’s transaction related to Nanoform Finland Plc’s CBO Antonio Da Silva’s acceptance of stock options: Person subject to the notification requirement Name: Antonio Da Silva Position: Other senior manager  Issuer: Nanoform Finland Oyj LEI: 743700JJO2NU8LBS1592 Notification type: INITIAL NOTIFICATION Reference number: 48931/8/8 Transaction date: 2024-01-10 Outside a

Nanoform Finland Plc – Manager’s transactions – Johanna Kause

Company release Nanoform Finland Plc January 10, 2024 23.00 Finnish time / 22.00 Swedish time Nanoform Finland Plc – Manager’s transactions – Johanna Kause Helsinki, Finland – Manager’s transaction related to Nanoform Finland Plc’s CQO Johanna Kause’s acceptance of stock options: Person subject to the notification requirement Name: Johanna Kause Position: Other senior manager  Issuer: Nanoform Finland Oyj LEI: 743700JJO2NU8LBS1592 Notification type: INITIAL NOTIFICATION Reference number: 48943/6/6 Transaction date: 2024-01-10 Outside a trading venue

The Board of Directors of Nanoform Finland Plc decided on issue of stock options under an option program open to all employees

Company release Nanoform Finland Plc January 10, 2024 23:00 Finnish time / 22:00 Swedish time The Board of Directors of Nanoform Finland Plc decided on issue of stock options under an option program open to all employees Helsinki, Finland – The Annual General Meeting of Nanoform Finland Plc (“Nanoform”) has on 12 April 2022 authorized the company’s Board of Directors to decide on the issuance of shares as well as the issuance of special rights entitling to shares referred to in Chapter 10 Section 1 of the Finnish Limited Liability Companies Act by one or several decisions.

Tranter to supply heat exchangers to carbon capture application in a new blue hydrogen plant in Texas, United States.

Pune, India. Tranter recently won a large order for post combustion carbon capture application. The order is for six (6) large plate and frame heat exchangers in stainless steel and 254 SMO with EPDM gaskets that will be used for heat recovery and vent condensers in the removal process of CO\2\ from a gas stream, carried out by absorption in a continuous process with regenerable solvents.The heat exchangers were ordered by a major EPC contractor in gas processing, separation and liquefaction technologies. While the engineering and procurement activities were done by their entity in India,

Nordea Bank Abp: Repurchase of own shares on 10.01.2024

Nordea Bank AbpStock exchange release – Changes in company’s own shares10.01.2024 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 10.01.2024 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+-------------------+-------------------+|XHEL |122,237|11.45 |1,399,100.

Isofol appoints Magnus Hurst as new Chief Financial Officer

GOTHENBURG, Sweden, January 10, 2024 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) today announces that the company has appointed Magnus Hurst as new Chief Financial Officer. He has broad financial experience and takes up the position with immediate effect.The information in the press release is intended for investors. Magnus Hurst has long experience in financial roles at companies such as SAS and within the Kinnevik Group. He currently holds a position as CFO and Head of Investor Relations at the biotech company Synartro and will combine this role with the new assignment as CFO

There are no items matching the current filter
There are no more items matching the current filter
Back to top